United States

Back to map

Showing 241-250 of 353 grants

Title Institution Researcher Program Duration Total Award Amount
Controlling cytoarchitecture and function in novel stem-cell-based implants intended for T1D therapy Mayo Clinic Quinn Peterson Cures 01-February-2026 to 31-January-2028 $600,000.00
A Nanosensor Embedded Device for Rapid Insulin Measurement Massachusetts Institute of Technology Michael Strano Improving Lives 01-April-2024 to 31-March-2027 $698,927.98
The T1D Parent Check-In: A Preventative Intervention Massachusetts General Hospital Ellen O’Donnell Improving Lives 01-July-2023 to 01-September-2026 $390,792.17
Understanding common tissue tolerance mechanisms in autoimmunity Massachusetts General Hospital Gary Reynolds Cures 01-September-2025 to 28-February-2027 $150,000.00
Epithelial Immune Sentinels in T1D Autoimmune Kidney Disease Massachusetts General Hospital Maria Agustina Battistone Improving Lives 01-September-2026 to 31-August-2028 $189,099.97
Development of a safe and effective islet-targeted nanoplasmid based CXCL12 gene delivery system using cationic nanobubble-mediated sonotransfection to restore and immune protect the residual beta cell mass in T1D Massachusetts General Hospital Mark Poznansky Cures 01-April-2023 to 31-March-2027 $777,168.00
Development and testing of protease-resistant CXCL12 loaded sub 100 micron polymeric microbeads to enable alloislet transplantation without systemic immune suppression in established murine models of type 1 diabetes Massachusetts General Hospital Mark Poznansky Cures 01-February-2026 to 31-January-2028 $599,448.76
INHALE-1st: Technosphere Insulin (Afrezza®) In Combination With Basal Insulin For Youth With Newly-Diagnosed Type 1 Diabetes Mannkind Ian Buckner Improving Lives 25-June-2026 to 24-June-2028 $600,000.00
Transcriptional memory in human islet organogenesis Lundquist Institute for Biomedical Medical Innovation at Harbor‐UCLA Medical Center (The Lundquist Institute) Eiji Yoshihara Cures 01-April-2022 to 31-March-2027 $749,995.50
Assessment of NovoSphere™ Hydrogel Encapsulation to Enable High-Loading and Extended Release of Tegoprubart for Subcutaneous Administration Likarda, Inc Lisa Stehno-Bittel Cures 15-June-2026 to 15-December-2026 $301,200.00